目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Primary interviews
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.4.1 STUDY-RELATED ASSUMPTIONS
2.4.2 GROWTH RATE ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 TRADITIONAL WOUND CARE MARKET OVERVIEW
4.2 ASIA PACIFIC: TRADITIONAL WOUND CARE MARKET, BY END USER AND COUNTRY (2024)
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 TRADITIONAL WOUND CARE MARKET, REGIONAL MIX, 2025 VS. 2030

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of diabetes
5.2.1.2 Growing geriatric population and subsequent rise in chronic wounds
5.2.1.3 Increasing incidence of burn injuries
5.2.1.4 Rising number of road accidents and trauma cases
5.2.1.5 Increasing expenditure on chronic wounds
5.2.2 RESTRAINTS
5.2.2.1 Limitations associated with traditional wound care
5.2.2.2 Rising adoption of advanced wound care technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Sustained adoption due to cost efficiency and wide accessibility
5.2.3.2 Growth potential of emerging economies
5.2.4 CHALLENGES
5.2.4.1 Limited awareness associated with wound care
5.3 PRICING ANALYSIS
5.3.1 INDICATIVE PRICE OF KEY PLAYERS, BY APPLICATION, 2025
5.3.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023-2025
5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY LANDSCAPE
5.8.1.1 North America
5.8.1.1.1 US
5.8.1.1.2 Canada
5.8.1.2 Europe
5.8.1.3 Asia Pacific
5.8.1.3.1 China
5.8.1.3.2 Japan
5.8.1.3.3 India
5.8.1.4 Latin America
5.8.1.4.1 Brazil
5.8.1.4.2 Mexico
5.8.1.5 Middle East & Africa
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 TRADE ANALYSIS
5.9.1 TRADE ANALYSIS FOR WADDING, GAUZE, AND BANDAGES
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES & EVENTS, 2025-2026
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 IMPACT OF AI/GENERATIVE AI ON TRADITIONAL WOUND CARE MARKET
5.14.1 INTRODUCTION
5.14.2 MARKET POTENTIAL FOR TRADITIONAL WOUND CARE
5.14.3 FUTURE OF GENERATIVE AI IN TRADITIONAL WOUND CARE
5.15 INVESTMENT & FUNDING SCENARIO
5.16 CASE STUDY ANALYSIS
5.16.1 HYDROCOLL HYDROCOLLOID DRESSINGS TO SUPPORT RAPID WOUND HEALING
5.17 TECHNOLOGY ANALYSIS
5.17.1 ADJACENT TECHNOLOGIES
5.17.1.1 Negative pressure wound therapy
5.17.2 COMPLEMENTARY TECHNOLOGIES
5.17.2.1 Bioactive dressings

6 TRADITIONAL WOUND CARE MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION
6.2 FIXATION PRODUCTS
6.2.1 ADHESIVE TAPES
6.2.1.1 Need for secure wound coverings and wound management to drive market
6.2.2 NON-ADHESIVE FIXATION PRODUCTS
6.2.2.1 Reduced swelling and minimized pain & trauma during dressing changes to support adoption
6.3 BANDAGES
6.3.1 WIDE USAGE OF BANDAGES AND CONTINUED DEMAND TO SUPPORT MARKET GROWTH
6.4 GAUZE
6.4.1 STERILE GAUZE
6.4.1.1 Woven gauze
6.4.1.1.1 Wide usage in surgeries and wound packing to propel market growth
6.4.1.2 Non-woven gauze
6.4.1.2.1 Enhanced absorption and wound coverage properties to drive usage
6.4.2 NON-STERILE GAUZE
6.4.2.1 Applications in cushioning, padding, and secondary dressing to support adoption
6.5 HYDROCOLLOID DRESSINGS
6.5.1 MOISTURE REGULATION AND BENEFITS IN REMOVING NECROTIC TISSUE TO DRIVE MARKET
6.6 FIRST-AID PLASTERS
6.6.1 NEED FOR RAPID WOUND MANAGEMENT AND PROTECTION TO PROPEL ADOPTION
6.7 ABSORBENT PADS
6.7.1 WIDE USAGE IN WOUND DRESSING AND EXUDATE MANAGEMENT TO DRIVE MARKET
6.8 COMPRESSION PRODUCTS
6.8.1 ALL COMPRESSION BANDAGES
6.8.1.1 Ability to reduce swelling for rapid recovery to boost demand
6.8.2 COMPRESSION SOCKS
6.8.2.1 Prevention of venous disorders to support market growth
6.9 DRESSINGS
6.9.1 ISLAND DRESSINGS
6.9.1.1 Waterproof, antimicrobial, and absorbent properties to drive greater demand
6.9.2 FILM DRESSINGS
6.9.2.1 Secure adhesion and protection from bacteria & contaminants to support market growth
6.10 OTHER TRADITIONAL WOUND CARE PRODUCTS

7 TRADITIONAL WOUND CARE MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 ACUTE WOUNDS
7.2.1 SURGICAL AND TRAUMATIC WOUNDS
7.2.1.1 Rising volume of surgical procedures to drive market growth
7.2.2 BURNS
7.2.2.1 High incidence of burn injuries to drive the market growth
7.3 CHRONIC WOUNDS
7.3.1 DIABETIC FOOT ULCERS
7.3.1.1 Increasing prevalence of diabetes to propel market growth
7.3.2 PRESSURE ULCERS
7.3.2.1 Rising prevalence of pressure ulcers to sustain demand for wound care
7.3.3 VENOUS LEG ULCERS
7.3.3.1 Rising prevalence of obesity to drive market
7.3.4 OTHER CHRONIC WOUNDS

8 TRADITIONAL WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
8.1 INTRODUCTION
8.2 HEALTHCARE INSTITUTIONS
8.2.1 RISING NUMBER OF TRAUMA CASES AND ROAD ACCIDENTS TO PROPEL MARKET
8.3 PHARMACIES & DRUG STORES
8.3.1 PROVISION OF SPECIALIZED OTC PRODUCTS TO DRIVE MARKET
8.4 SUPERMARKETS
8.4.1 WIDE ACCESSIBILITY TO NUMEROUS PRODUCTS TO FUEL MARKET
8.5 HOME CARE SETTINGS
8.5.1 BENEFITS OF CONVENIENCE AND AFFORDABILITY TO BOOST DEMAND
8.6 OTHER DISTRIBUTION CHANNELS

9 TRADITIONAL WOUND CARE MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS & CLINICS
9.2.1 INPATIENT SETTINGS
9.2.1.1 Increasing hospital admissions due to HAIs to drive market
9.2.2 OUTPATIENT SETTINGS
9.2.2.1 Adoption of specialized wound care products to fuel market
9.3 HOME HEALTHCARE
9.3.1 PROVISION OF ASSISTED LIVING AND SKILLED NURSING TO PROPEL MARKET
9.4 AMBULATORY SURGERY CENTERS
9.4.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET
9.5 OTHER END USERS

10 TRADITIONAL WOUND CARE MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 Rising prevalence of diabetes and favorable reimbursement policies to drive market
10.2.3 CANADA
10.2.3.1 Favorable government support for skin & wound care to support market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 High prevalence of HAIs to propel market
10.3.3 UK
10.3.3.1 Increasing cases of burn injuries to support market adoption
10.3.4 FRANCE
10.3.4.1 High number of accidents to fuel market
10.3.5 ITALY
10.3.5.1 Growing accessibility to advanced medical care to boost demand
10.3.6 SPAIN
10.3.6.1 Rising geriatric population and subsequent increase in injuries to support market adoption
10.3.7 CZECH REPUBLIC
10.3.7.1 Rising incidence of diabetes to fuel uptake
10.3.8 SWITZERLAND
10.3.8.1 Rising incidence of chronic diseases to boost demand
10.3.9 POLAND
10.3.9.1 Improvements in healthcare infrastructure to favor market growth
10.3.10 AUSTRIA
10.3.10.1 Increasing initiatives to spread awareness of effective wound care to boost demand
10.3.11 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Increasing incidence of diabetic foot ulcers among geriatric population to drive market
10.4.3 JAPAN
10.4.3.1 Presence of well-developed healthcare system and favorable government policies to favor market growth
10.4.4 INDIA
10.4.4.1 Growing medical tourism and increasing diabetes population to support market growth
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Increased healthcare expenditure and need for wound management for athletes to drive market
10.5.3 MEXICO
10.5.3.1 Increasing traffic fatalities and injuries to boost market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 RISING GERIATRIC POPULATION AND GROWING PREVALENCE OF DIABETES TO BOOST MARKET
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TRADITIONAL WOUND CARE MARKET
11.3 REVENUE ANALYSIS, 2022-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Application footprint
11.5.5.5 Fixation products footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of key startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 COMPANY VALUATION
11.7.2 FINANCIAL METRICS
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 SOLVENTUM
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 CARDINAL HEALTH
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Deals
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 ESSITY AKTIEBOLAG
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Expansions
12.1.3.3.2 Other developments
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 PAUL HARTMANN AG
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Deals
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses & competitive threats
12.1.5 MOLNLYCKE AB
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 BEIERSDORF
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Product launches
12.1.6.3.2 Deals
12.1.6.3.3 Expansions
12.1.7 B. BRAUN SE
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Deals
12.1.7.3.2 Expansions
12.1.8 OWENS & MINOR, INC.
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 KENVUE
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 SMITH+NEPHEW
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Deals
12.1.11 NITTO DENKO CORPORATION
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 MCKESSON CORPORATION
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.12.3 Recent developments
12.1.12.3.1 Deals
12.2 OTHER PLAYERS
12.2.1 DYNAREX CORPORATION
12.2.2 MEDLINE INDUSTRIES, LP
12.2.3 LOHMANN & RAUSCHER GMBH & CO. KG
12.2.4 MEDICOM
12.2.5 WINNER MEDICAL CO., LTD.
12.2.6 VERNACARE LTD.
12.2.7 GF HEALTH PRODUCTS, INC.
12.2.8 DR. AUSBUTTEL & CO. GMBH
12.2.9 DERMARITE INDUSTRIES, LLC.
12.2.10 GENTELL
12.2.11 DEROYAL INDUSTRIES, INC.
12.2.12 URGO MEDICAL
12.2.13 DUKAL, LLC

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS